您的位置: 首页 > 农业专利 > 详情页

PYRROLOTRIAZINE DERIVATIVES AS KINASE INHIBITOR
专利权人:
LTD.;DAEWOONG PHARMACEUTICAL CO.
发明人:
KIM, In Woo (KR),КИМ, Ин У (KR),YOO, Ja Kyung (KR),ЙОО, Дза Киунг (KR),KIM, Ji Duck (KR),КИМ, Чи Дук (KR),JUN, Sun Ah (KR),ЧОН, Сон А (KR),LEE, Jun Hee (KR),ЛИ, Чон Хи (KR)
申请号:
RU2019123998
公开号:
RU0002726632C1
申请日:
2018.03.19
申请国别(地区):
RU
年份:
2020
代理人:
摘要:
FIELD: chemistry.SUBSTANCE: present invention relates to a compound of chemical formula 1, having inhibitory activity on janus-kinase (JAK3) and Bruton tyrosine kinase (BTK), or a pharmaceutically acceptable salt thereof. In one embodiment, in chemical formula 1, X is O; A is a ring selected from a group consisting of benzothiazole, isothiazole, isoxazole, pyrazole, pyrrole, thiazole, thiophene and 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine; R1 denotes hydrogen; C1-4 alkyl, unsubstituted or substituted with one substitute selected from a group consisting of C1-4 alkoxy and N(C1-4 alkyl)2; C1-4 alkoxy; C1-4 haloalkyl; C3-6 cycloalkyl; N(C1-4 alkyl)2; pyrazolyl unsubstituted or substituted with one or two C1-4 alkyl groups; or , where Y1 is NH, N(C1-4 alkyl) or O; Y2 is CH or N; L is a bond, C1-4 alkylene or CO; R2 denotes hydrogen, C1-4 alkyl or halogen, and R3 is C1-4 alkyl substituted with halogen; C2-4 alkenyl unsubstituted or substituted with halogen; or C2-4 alkynyl. In another embodiment in chemical formula 1 X is O; A is a ring selected from the group consisting of benzene and pyridine; R1 denotes hydrogen; C1-4 alkyl, unsubstituted or substituted with one substitute selected from a group consisting of C1-4 alkoxy and N (C1-4 alkyl)2 ; C1-4 alkoxy; C1-4 haloalkyl; C3-6 cycloalkyl; N(C1-4 alkyl)2; pyrazolyl unsubstituted or substituted with one or two C1-4 alkyl groups; or , where Y1 is NH, N (C1-4 alkyl) or O; Y2 is CH or N; L is a bond, C1-4 alkylene or CO; R2 is halogen, and R3 is C1-4 alkyl substituted with halogen; C2-4 alkenyl unsubstituted or substituted with halogen; or C2-4 alkynyl. Present invention also refers to a pharmaceutical composition containing said compounds or their pharmaceutically acceptable salts.[chemical formula 1].EFFECT: pharmaceutical composition can be used for preventing or treating an inflammatory disease, an autoimmune disease, a proliferative disease, a hyperproliferative disease, an immuno-mediated disease, cancer or tumour.9 c
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充